

Key updates in ALL at EHA 2020
Jul 7, 2020
Researchers from Spain, the US, and Austria discuss key updates in acute lymphoblastic leukemia (ALL) at EHA 2020 congress, including the role of the gut microbiome in disease development, modulation of the gut microbiome for prevention, efficacy and toxicity of novel agents in ALL treatment, and the use of total body irradiation in children and adolescents with ALL.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
The Role of the Gut Microbiome in Disease Development
03:02 • 3min
Modulation of Gut Microbiome and Multi-Cohort Analysis of Novel Agents in Leukemia Treatment
06:09 • 3min
Response Rates and Treatment Options for ALL Patients
09:13 • 3min
The Use of Total Body Irradiation in the Treatment of Acute Lymphoblastic Leukemia
12:43 • 3min